• Home
  • News
2021-07-06 | views:1146
mRNA 준비된 한미약품, WHO '백신허브' 선정 노린다
2021-07-01 | views:1061
NIH visits Hanmi Fine Chemical to verify mRNA technology
2021-07-01 | views:833
한미정밀화학 "국립보건연구원이 방문해 mRNA원료기술 현장검증"
2021-06-30 | views:2263
Team Korea formed to develop mRNA vaccine for complete self-sufficiency by next yr
2021-06-18 | views:701
떠오르는 디지털 치료제, '대형 제약사' 관심도 증가
2021-06-17 | views:1265
What policy does Korea need to achieve vaccine hub ambition?
2021-06-16 | views:619
임종윤 한미사이언스 대표 “mRNA 백신 원액 단기간 내 공급 가능하다”
2021-06-15 | views:926
"백신 개발은 방위산업…컨소시엄 구축하고 대규모 투자로 자체 mRNA 개발해야"
2021-06-13 | views:2799
G7 announces pledges of 870 million COVID-19 vaccine doses, of which at least half to be delivered by the end of 2021
  1.   
  2. 36
  3. 37
  4. 38
  5. 39
  6. 40
  7. 41
  8. 42
  9. 43
  • 10F, 173, Digital-ro, Geumcheon-gu, Seoul (Gasan-dong, Elysian)
  • Tel : 02-890-8700
  • IR Service : 02-6964-8770
  • Fax : 02-6964-8755

About Us

Goals & Promise

Leadership

Company History

IR

Notice & IR

Disclosure Information

Dx&Vx 2023 Award Impact

Contact

Private Policy Terms of Use twitter icon @dxvx_official
© 2024 Dx&Vx. All Rights Reserved.